Abstract
PSS16 - Cumulative Cost of Treatment with ILUVIEN (Fluocinolone Acetonide [FAC]) Versus the Current Standard of Care in the Treatment of Visual Impairment Due to Diabetic Macular Oedema (DMO) in Phakic Eyes Over a 3 Year Period: An Analysis from a UK Healthcare Perspective
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have